Given the state of political affairs currently engulfing health care, our industry regularly gets vilified and is frequently a victim of misperception.
Dan Steiber, RPh, Specialty Pharmacy Times® Editor-In-Chief & Executive Vice President
Advertisement
Articles by Dan Steiber, RPh, Specialty Pharmacy Times® Editor-In-Chief & Executive Vice President
The meteoric rise in drug spending over the past 10 years has been driven by specialty therapeutics, while spending on traditional therapies has decreased.
Advertisement
Latest Updated Articles
Patients First: Is Specialty Pharmacy in the Blueprint?July 18th 2018
Community “Specialty†Pharmacy vs the CompetitionSeptember 10th 2018
Advertisement
Advertisement
Trending on Pharmacy Times
1
Early Recognition and Routine Discussion: Improving Outcomes in Tardive Dyskinesia
2
Targeting CSF1R in TGCT: Evaluating the Evidence and Empowering Pharmacist-Led Care
3
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
4
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
5